SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000248
Filing Date
2021-05-17
Accepted
2021-05-17 07:26:10
Documents
45
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q labp-20210331.htm   iXBRL 10-Q 1172332
2 EX-31.1 labp-20210331-ex31_1.htm EX-31.1 15920
3 EX-32.1 labp-20210331-ex32_1.htm EX-32.1 9009
  Complete submission text file 0000950170-21-000248.txt   4325313

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT labp-20210331_def.xml EX-101.DEF 83791
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT labp-20210331_lab.xml EX-101.LAB 312231
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT labp-20210331_pre.xml EX-101.PRE 203546
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT labp-20210331_cal.xml EX-101.CAL 31457
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT labp-20210331.xsd EX-101.SCH 27867
9 EXTRACTED XBRL INSTANCE DOCUMENT labp-20210331_htm.xml XML 638212
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39971 | Film No.: 21927541
SIC: 2834 Pharmaceutical Preparations